Immunogenicity and Safety of 3 Formulations of a Respiratory Syncytial Virus Candidate Vaccine in Nonpregnant Women: A Phase 2, Randomized Trial

BACKGROUND: Respiratory syncytial virus (RSV) is a common cause of respiratory tract illness and hospitalization in neonates and infants. RSV vaccination during pregnancy may protect offspring in their first months of life. METHODS: This randomized, observer-blind, multicenter, phase 2 study evaluat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:J Infect Dis
Autors principals: Schwarz, Tino F, McPhee, Roderick A, Launay, Odile, Leroux-Roels, Geert, Talli, Jaak, Picciolato, Marta, Gao, Feng, Cai, Rongman, Nguyen, Thi Lien-Anh, Dieussaert, Ilse, Miller, Jacqueline M, Schmidt, Alexander C
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Major Articles and Brief Reports
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6898794/
https://ncbi.nlm.nih.gov/pubmed/31418022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiz395
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars